跳至主要内容
临床试验/NCT05321511
NCT05321511Unknown4 期

Double Ovarian Stimulation (DuoStim) Comparison of Triggers: Is There Any Advantage Using 3 Different Methods of Trigger for the Second Egg Collection in Predicted Low Responders?

Instituto Bernabeu1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2022年3月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
165
试验地点
1
主要终点
number of retrieved oocytes

研究概览

简要总结

This study aims to investigate the efficacy of 3 different trigggers used for final maturation in the second ovarian stimulation in double stimulation protocol (aGnRH and hCG-rec vs. aGnRH only vs. hCG-rec only). The main objective is to compare the number of all retrieved oocytes and mature oocytes in patients predicted to be low ovarian responders.

This is a controlled randomized clinical study where 165 patients will be recruited.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
28 Years 至 43 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • BMI below 32
  • Presence of both ovaries
  • Indication for ovarian stimulation under Double Stimulation protocol (Duo Stim)
  • Meeting the criteria for Duo Stim
  • Medical history, history and physical examination without alterations
  • AMH and AFV results in accordnace to Poseidon classification group 3 or 4 no more than 6 months prior to signing the consent form
  • Ability to participate and comply with the study protocol.
  • To have given written consent
  • Normal karyotype and fragile X.

排除标准

  • Non-compliance with instructions and/or non-formalization of consents or legal requirements for IVF.
  • Concurrent participation in another study

研究组 & 干预措施

a-GnRH

Active Comparator

Administration of triptorelin acetate 0.2 mg for final oocyte maturation.

干预措施: Triptorelin acetate (a-GnRH) (Drug)

hCG

Active Comparator

Administration of coriogonadotropine alfa 250 mcg for final oocyte maturation.

干预措施: Ovitrelle® (hCG) (Drug)

a-GnRH + hCG

Experimental

Administration of triptorelin acetate 0.2 mg and coriogonadotropine alfa 250 mcg for final oocyte maturation.

干预措施: Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together (Drug)

结局指标

主要结局

number of retrieved oocytes

时间窗: through study completion, usually will be evaluated on the last day of the treatment

number of oocytes retrieved in the second ovarian stimulation in the double stimulation protocol.

number of mature (MII) oocytes

时间窗: through study completion, usually will be evaluated on the last day of the treatment

number of mature (MII) oocytes retrieved in the second ovarian stimulation in the double stimulation protocol.

次要结局

未报告次要终点

研究者

发起方
Instituto Bernabeu
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Bernabeu García

Co-Director

Instituto Bernabeu

研究点 (1)

Loading locations...

相似试验